{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:54:08Z","timestamp":1775102048608,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,4,2]],"date-time":"2017-04-02T00:00:00Z","timestamp":1491091200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00520-017-3670-3","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T23:45:30Z","timestamp":1491090330000},"page":"2593-2601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients"],"prefix":"10.1007","volume":"25","author":[{"given":"Dipenkumar","family":"Modi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyejeong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malini","family":"Surapaneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamya","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Deol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois","family":"Ayash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divaya","family":"Bhutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence G.","family":"Lum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Voravit","family":"Ratanatharathorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Manasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendra","family":"Mellert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranatharthi","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.","family":"Uberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,2]]},"reference":[{"issue":"4","key":"3670_CR1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01650752","volume":"16","author":"F Petersen","year":"1988","unstructured":"Petersen F, Thornquist M, Buckner C et al (1988) The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study. Infection 16(4):199\u2013208","journal-title":"Infection"},{"issue":"1","key":"3670_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/08880019409141902","volume":"11","author":"M Avril","year":"1994","unstructured":"Avril M, Hartmann O, Valteau-Couanet D, Brugieres L, Kalifa C, Lemerle J (1994) Antiinfective prophylaxis with ceftazidime and teicoplanin in children undergoing high-dose chemotherapy and bone marrow transplantation. Pediatr Hematol Oncol 11(1):63\u201373","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"3670_CR3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1086\/515103","volume":"28","author":"EA Engels","year":"1999","unstructured":"Engels EA, Ellis CA, Supran SE et al (1999) Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis 28(2):256\u2013266","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3670_CR4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbmt.2013.03.019","volume":"19","author":"J Hong","year":"2013","unstructured":"Hong J, Moon SM, Ahn HK et al (2013) Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 19(6):994\u2013999","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"3670_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jinf.2014.02.013","volume":"69","author":"S Kimura","year":"2014","unstructured":"Kimura S, Akahoshi Y, Nakano H et al (2014) Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials. The Journal of infection 69(1):13\u201325","journal-title":"The Journal of infection"},{"issue":"Suppl 2","key":"3670_CR6","doi-asserted-by":"crossref","first-page":"S359","DOI":"10.1093\/clinids\/17.Supplement_2.S359","volume":"17","author":"J Verhoef","year":"1993","unstructured":"Verhoef J (1993) Prevention of infections in the neutropenic patient. Clin Infect Dis 17(Suppl 2):S359\u2013S367","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3670_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00006454-199701000-00038","volume":"16","author":"CC Patrick","year":"1997","unstructured":"Patrick CC (1997) Use of fluoroquinolones as prophylactic agents in patients with neutropenia. Pediatr Infect Dis J 16(1):135\u2013139 discussion 160-132","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"3670_CR8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0959-8049(05)80252-7","volume":"29A","author":"A Del Favero","year":"1993","unstructured":"Del Favero A, Menichetti F (1993) The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients. Eur J Cancer 29A(Suppl 1):S2\u2013S6","journal-title":"Eur J Cancer"},{"issue":"10","key":"3670_CR9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","volume":"353","author":"G Bucaneve","year":"2005","unstructured":"Bucaneve G, Micozzi A, Menichetti F et al (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353(10):977\u2013987","journal-title":"N Engl J Med"},{"issue":"10","key":"3670_CR10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJMoa050078","volume":"353","author":"M Cullen","year":"2005","unstructured":"Cullen M, Steven N, Billingham L et al (2005) Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 353(10):988\u2013998","journal-title":"N Engl J Med"},{"issue":"7","key":"3670_CR11","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s10096-011-1489-2","volume":"31","author":"BS Sohn","year":"2012","unstructured":"Sohn BS, Yoon DH, Kim S et al (2012) The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience. Eur J Clin Microbiol Infect Dis 31(7):1653\u20131661","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3670_CR12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/1471-2334-13-356","volume":"13","author":"M Garnica","year":"2013","unstructured":"Garnica M, Nouer SA, Pellegrino FL, Moreira BM, Maiolino A, Nucci M (2013) Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance. BMC Infect Dis 13:356","journal-title":"BMC Infect Dis"},{"issue":"17","key":"3670_CR13","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJM199404283301717","volume":"330","author":"A Cometta","year":"1994","unstructured":"Cometta A, Calandra T, Bille J, Glauser MP (1994) Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med 330(17):1240\u20131241","journal-title":"N Engl J Med"},{"issue":"9","key":"3670_CR14","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J Pepin","year":"2005","unstructured":"Pepin J, Saheb N, Coulombe MA et al (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41(9):1254\u20131260","journal-title":"Clin Infect Dis"},{"issue":"23","key":"3670_CR15","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMe058221","volume":"353","author":"JG Bartlett","year":"2005","unstructured":"Bartlett JG, Perl TM (2005) The new Clostridium difficile\u2014what does it mean? N Engl J Med 353(23):2503\u20132505","journal-title":"N Engl J Med"},{"issue":"11","key":"3670_CR16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ajh.21855","volume":"85","author":"E Eleutherakis-Papaiakovou","year":"2010","unstructured":"Eleutherakis-Papaiakovou E, Kostis E, Migkou M et al (2010) Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial. Am J Hematol 85(11):863\u2013867","journal-title":"Am J Hematol"},{"key":"3670_CR17","first-page":"CD004386","volume":"1","author":"A Gafter-Gvili","year":"2012","unstructured":"Gafter-Gvili A, Fraser A, Paul M et al (2012) Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. The Cochrane database of systematic reviews 1:CD004386","journal-title":"The Cochrane database of systematic reviews"},{"issue":"1","key":"3670_CR18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2478\/v10039-012-0004-z","volume":"57","author":"A Wolska","year":"2012","unstructured":"Wolska A, Robak T, Szmigielska-Kaplon A, Pluta A, Kopka P, Wierzbowska A (2012) Ciprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT)\u2014a single-center experience. Adv Med Sci 57(1):118\u2013123","journal-title":"Adv Med Sci"},{"issue":"2","key":"3670_CR19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijantimicag.2011.10.009","volume":"39","author":"JJ Vehreschild","year":"2012","unstructured":"Vehreschild JJ, Moritz G, Vehreschild MJ et al (2012) Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial. Int J Antimicrob Agents 39(2):130\u2013134","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"3670_CR20","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 52(4):e56\u2013e93","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3670_CR21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/513764","volume":"25","author":"WT Hughes","year":"1997","unstructured":"Hughes WT, Armstrong D, Bodey GP et al (1997) 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 25(3):551\u2013573","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3670_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00277-002-0567-z","volume":"82","author":"SP Yeh","year":"2003","unstructured":"Yeh SP, Chiu CF, Lo WJ et al (2003) Low infectious morbidity in patients with heavily pretreated hematological malignancies receiving autologous peripheral blood stem cell transplantation without antimicrobial prophylaxis. Ann Hematol 82(1):24\u201329","journal-title":"Ann Hematol"},{"issue":"1","key":"3670_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.bmt.1701520","volume":"23","author":"R Salazar","year":"1999","unstructured":"Salazar R, Sola C, Maroto P et al (1999) Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23(1):27\u201333","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"3670_CR24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00277-013-1872-4","volume":"93","author":"JL Pinana","year":"2014","unstructured":"Pinana JL, Montesinos P, Martino R et al (2014) Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients. Ann Hematol 93(2):299\u2013307","journal-title":"Ann Hematol"},{"issue":"11","key":"3670_CR25","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1086\/340352","volume":"34","author":"RR Razonable","year":"2002","unstructured":"Razonable RR, Litzow MR, Khaliq Y, Piper KE, Rouse MS, Patel R (2002) Bacteremia due to viridans group Streptococci with diminished susceptibility to levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis 34(11):1469\u20131474","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3670_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-106-1-1","volume":"106","author":"JE Karp","year":"1987","unstructured":"Karp JE, Merz WG, Hendricksen C et al (1987) Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 106(1):1\u20137","journal-title":"Ann Intern Med"},{"issue":"5","key":"3670_CR27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9343(88)90062-9","volume":"84","author":"EJ Bow","year":"1988","unstructured":"Bow EJ, Rayner E, Louie TJ (1988) Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. Am J Med 84(5):847\u2013854","journal-title":"Am J Med"},{"issue":"11","key":"3670_CR28","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/340402","volume":"34","author":"AR Tunkel","year":"2002","unstructured":"Tunkel AR, Sepkowitz KA (2002) Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 34(11):1524\u20131529","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3670_CR29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkl425","volume":"59","author":"A Gafter-Gvili","year":"2007","unstructured":"Gafter-Gvili A, Paul M, Fraser A, Leibovici L (2007) Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis. J Antimicrob Chemother 59(1):5\u201322","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"3670_CR30","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.clml.2015.05.008","volume":"15","author":"M Veeraputhiran","year":"2015","unstructured":"Veeraputhiran M, Jain T, Deol A et al (2015) BEAM conditioning regimen has higher toxicity compared with high-dose melphalan for salvage autologous hematopoietic stem cell transplantation in multiple myeloma. Clin Lymphoma, Myeloma Leuk 15(9):531\u2013535","journal-title":"Clin Lymphoma, Myeloma Leuk"},{"issue":"2","key":"3670_CR31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/bmt.2008.299","volume":"43","author":"S McCann","year":"2009","unstructured":"McCann S, Schwenkglenks M, Bacon P et al (2009) The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone Marrow Transplant 43(2):141\u2013147","journal-title":"Bone Marrow Transplant"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-3670-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3670-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3670-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T20:55:24Z","timestamp":1601844924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-3670-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,2]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["3670"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-3670-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,2]]}}}